Clin. Invest. 125, 593–606 (2015). 6. Melief, C. J. Mutation-specific T cells for immunotherapy of gliomas. N. Engl. J. Med. 372, 1956–1958 (2015). 7. Pellegatta, S. et al. Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma. Acta Neuropathol. Commun. 3, 4 (2015). 8. Bunse, L. et al. Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. Nat.